This Mom Saw Success on GLP-1s, but Cost Was 'Becoming Prohibitive.' On July 1, Medicare's $50 Pricing Will Change That

CMS Launches Medicare GLP-1 Bridge, Expanding Access to GLP-1 Medications

Medicare Launches $50/Month GLP-1 Weight-Loss Drug Trial: What Beneficiaries Need to Know

Starting this week, the federal government launched a new trial program called Medicare GLP-1 Bridge, offering certain GLP-1 agonist medicat

Medicare begins covering weight-loss medications: who qualifies and how the new program will work

Conflicts of interest threaten integrity of GLP-1 therapy guidance, experts warn

This article discusses the risks of conflicts of interest in clinical guidance for GLP-1 receptor agonists (like Ozempic, Wegovy) used for o

GLP-1 weight loss drugs reduce food spending, creating a $6.5 billion challenge for major grocery retailers

The article discusses how GLP-1 weight loss drugs like tirzepatide are significantly impacting consumer spending on food, creating a $6.5 bi

Conflicts of interest threaten integrity of GLP-1 therapy guidance amid rapid adoption

This article discusses the rapid uptake and commercial success of GLP-1 receptor agonists for obesity management, highlighting their clinica